Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce M Robinson

Showing results (11-20 of 206) with videos related to

Pageof 21
Sort By:
Nephron|June 27, 2018
Patterns of Erythropoiesis-Stimulating Agent Use in European Hemodialysis Patients: The Dialysis Outcomes and Practice Patterns StudyDouglas S Fuller, Bruce M Robinson, Francesco Locatelli, et al.
Journal of the American Society of Nephrology : JASN|July 2, 2020
At the Crossroads for Intravenous Iron DosingAbhijit V Kshirsagar, Xiaojuan Li, Bruce M Robinson, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 10, 2015
Trends in US Vascular Access Use, Patient Preferences, and Related Practices: An Update From the US DOPPS Practice Monitor With International ComparisonsRonald L Pisoni, Lindsay Zepel, Friedrich K Port, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 27, 2012
Dialysis Outcomes and Practice Patterns Study (DOPPS): its strengths, limitations, and role in informing practices and policiesBruce M Robinson, Brian Bieber, Ronald L Pisoni, et al.
Blood Purification|August 4, 2011
Absence of anemia in hemodialysis patientsDavid A Goodkin, Douglas S Fuller, Bruce M Robinson, et al.
American Journal of Nephrology|November 7, 2013
Hepatitis C infection is very rarely treated among hemodialysis patientsDavid A Goodkin, Brian Bieber, Brenda Gillespie, et al.
Seminars in Dialysis|September 11, 2014
Dialysate bicarbonate and the risk of deathFrancesca Tentori, Hal Morgenstern, Angelo Karaboyas, et al.
Clinical Epidemiology|November 18, 2020
Replicating Randomized Trial Results with Observational Data Using the Parametric g-Formula: An Application to Intravenous Iron Treatment in Hemodialysis PatientsAngelo Karaboyas, Hal Morgenstern, Nancy L Fleischer, et al.
Journal of the American Society of Nephrology : JASN|December 19, 2018
Projecting ESRD Incidence and Prevalence in the United States through 2030Keith P McCullough, Hal Morgenstern, Rajiv Saran, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 5, 2015
Hemodialysis Facility Variation in Hospitalization and Transfusions Using Medicare Claims: The DOPPS Practice Monitor for US Dialysis CareDouglas S Fuller, Lindsay Zepel, Brian A Bieber, et al.
Pageof 21

Showing results (11-20 of 206) with videos related to

Sort By:
Pageof 21
Nephron|June 27, 2018
Patterns of Erythropoiesis-Stimulating Agent Use in European Hemodialysis Patients: The Dialysis Outcomes and Practice Patterns StudyDouglas S Fuller, Bruce M Robinson, Francesco Locatelli, et al.
Journal of the American Society of Nephrology : JASN|July 2, 2020
At the Crossroads for Intravenous Iron DosingAbhijit V Kshirsagar, Xiaojuan Li, Bruce M Robinson, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 10, 2015
Trends in US Vascular Access Use, Patient Preferences, and Related Practices: An Update From the US DOPPS Practice Monitor With International ComparisonsRonald L Pisoni, Lindsay Zepel, Friedrich K Port, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 27, 2012
Dialysis Outcomes and Practice Patterns Study (DOPPS): its strengths, limitations, and role in informing practices and policiesBruce M Robinson, Brian Bieber, Ronald L Pisoni, et al.
Blood Purification|August 4, 2011
Absence of anemia in hemodialysis patientsDavid A Goodkin, Douglas S Fuller, Bruce M Robinson, et al.
American Journal of Nephrology|November 7, 2013
Hepatitis C infection is very rarely treated among hemodialysis patientsDavid A Goodkin, Brian Bieber, Brenda Gillespie, et al.
Seminars in Dialysis|September 11, 2014
Dialysate bicarbonate and the risk of deathFrancesca Tentori, Hal Morgenstern, Angelo Karaboyas, et al.
Clinical Epidemiology|November 18, 2020
Replicating Randomized Trial Results with Observational Data Using the Parametric g-Formula: An Application to Intravenous Iron Treatment in Hemodialysis PatientsAngelo Karaboyas, Hal Morgenstern, Nancy L Fleischer, et al.
Journal of the American Society of Nephrology : JASN|December 19, 2018
Projecting ESRD Incidence and Prevalence in the United States through 2030Keith P McCullough, Hal Morgenstern, Rajiv Saran, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 5, 2015
Hemodialysis Facility Variation in Hospitalization and Transfusions Using Medicare Claims: The DOPPS Practice Monitor for US Dialysis CareDouglas S Fuller, Lindsay Zepel, Brian A Bieber, et al.
Pageof 21